APA (7th ed.) Citation

YB, P., L, H., M, C., Q, Z., WL, J., Q, C., . . . S, G. (2024). Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology. ACS medicinal chemistry letters, 15(2), 181. https://doi.org/10.1021/acsmedchemlett.3c00455

Chicago Style (17th ed.) Citation

YB, Poudel, et al. "Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With APD1 for Use in Immuno-oncology." ACS Medicinal Chemistry Letters 15, no. 2 (2024): 181. https://doi.org/10.1021/acsmedchemlett.3c00455.

MLA (9th ed.) Citation

YB, Poudel, et al. "Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With APD1 for Use in Immuno-oncology." ACS Medicinal Chemistry Letters, vol. 15, no. 2, 2024, p. 181, https://doi.org/10.1021/acsmedchemlett.3c00455.